| [1] |
Qian Xiaotao, Shi Ziyi, Hu Ge, Wu Xiaowei.
Efficacy of consolidation chemotherapy after radical radiotherapy and chemotherapy for stage Ⅲ-ⅣA esophageal squamous cell carcinoma： a real-world clinical study
[J]. Journal of International Oncology, 2024, 51(6): 326-331.
|
| [2] |
Wang Kun, Zhou Zhongxin, Zang Qiwei.
Predictive value of serum TGF-β1 and VEGF levels in patients with non-small cell lung cancer after single-port thoracoscopic radical resection
[J]. Journal of International Oncology, 2024, 51(4): 198-203.
|
| [3] |
Yan Aiting, Wang Cuizhu, Liu Chungui, Lu Xiaomin.
Clinical efficacy and safety of camrelizumab and sintilimab in the treatment of advanced non-small cell lung cancer
[J]. Journal of International Oncology, 2024, 51(3): 137-142.
|
| [4] |
Jiang Xi, Wu Yongcun, Liang Yan, Chu Li, Duan Yingxin, Wang Lijun, Huo Junjie.
Impact of pembrolizumab combined with chemotherapy on angiogenesis and circulating endothelial cells in patients with advanced non-small cell lung cancer
[J]. Journal of International Oncology, 2024, 51(2): 89-94.
|
| [5] |
Gao Xinyu, Li Zhenjiang, Sun Hongfu, Han Dan, Zhao Qian, Liu Chengxin, Huang Wei.
Clinical application of MR-guided radiotherapy based on MR-linac in esophageal cancer patients
[J]. Journal of International Oncology, 2024, 51(1): 37-42.
|
| [6] |
Zhao Yongrui, Gao Ying, Chen Yidong, Xu Jiankun.
Efficacy and safety of linear accelerator-based fractionated stereotactic radiotherapy for small volume brain metastases
[J]. Journal of International Oncology, 2023, 50(3): 138-143.
|
| [7] |
Zhou Ting, Xu Shaohua, Mei Lin.
Efficacy and safety of bevacizumab combined with capecitabine in the treatment of advanced breast cancer
[J]. Journal of International Oncology, 2023, 50(3): 144-149.
|
| [8] |
Cao Mengqing, Xu Zhiyong, Shi Yuting, Wang Kai.
Role of tertiary lymphoid structures in tumor immune microenvironment regulation and anti-tumor therapy
[J]. Journal of International Oncology, 2023, 50(3): 169-173.
|
| [9] |
Wang Bing, Wang Aifu, Liu Wenshu, Fan Jiaojiao, Tian Weicheng, Wang Weili, Liu Boyu.
The efficacy and safety of recombinant human thrombopoietin in the treatment of thrombocytopenia caused by tumor radiotherapy
[J]. Journal of International Oncology, 2023, 50(11): 661-667.
|
| [10] |
Liu Song, Yu Guangji, Wang Qingdong.
Efficacy and influencing factors of DEBIRI-TACE combined with regorafenib in the third-line or above treatment of colorectal cancer liver metastases
[J]. Journal of International Oncology, 2022, 49(7): 400-407.
|
| [11] |
Cai Gangxiang, Li Jing, Xu Bin.
Advances in neoadjuvant immunotherapy for lung cancer
[J]. Journal of International Oncology, 2022, 49(6): 366-370.
|
| [12] |
Ding Xinjing, Ding Jianghua.
Research progress on the correlation between dermatological immune-related adverse events and clinical outcome of PD-1/PD-L1 inhibitors
[J]. Journal of International Oncology, 2022, 49(4): 225-228.
|
| [13] |
Lin Rongsheng, Wu Chuhai, Guo Yingmei, Wang Tao, Chen Rongbin, Liu Shaoqin, Gan Bing.
Efficacy and safety of teriprizumab combined with bevacizumab in the treatment of metastatic MSI-H colorectal cancer above the second line
[J]. Journal of International Oncology, 2022, 49(2): 100-105.
|
| [14] |
Wang Bin, Zhou Jiangyun, Liu Xi.
Analysis of the clinical value of different radiotherapy schemes in patients with advanced esophageal squamous cell carcinoma
[J]. Journal of International Oncology, 2021, 48(8): 484-488.
|
| [15] |
Du Xiao, Zhou Juying.
Stereotactic body radiotherapy for localized prostate cancer
[J]. Journal of International Oncology, 2021, 48(5): 313-316.
|
